« Back to Record
Kaufman, P. P., Perez, E. A., Olivo, M., He, Y., Dutcus, C. C., Awada, A., Twelves, C., Velikova, G., Yelle, L., & Cortes, J. (2015). Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane. Journal of clinical oncology, 33(6), 594-601. doi:10.1200/JCO.2013.52.4892
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/195930



